Clinical Trial Update: Immune Responses After a Booster Immunisation With IXIARO® in Elderly Compared to Young Individuals. [Phase 4]

View source ↗

Summary

Phase 4 trial update on immune responses after booster immunisation with IXIARO in elderly vs young individuals.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Japanese Encephalitis

Drugs mentioned

• IXIARO (inactivated Japanese encephalitis vaccine)

Snippet

Sponsor: Medical University of Vienna | Conditions: Japanese Encephalitis Vaccine | Phase 4 | Status: UNKNOWN